Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MERCK & CO., INC.

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Merck & Co., Inc.
Merck & Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through two segments: Pharmaceutical and Animal Health. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products. Its human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers such as health maintenance organizations. The Animal Health segment develops, manufactures and markets a wide range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all major livestock and companion animal species.

Number of employees : 74 000 people.
Sales per Business
20192020Delta
Pharmaceutical41 751.0089.6%43 021.0089.6% +3.04%
Animal Health4 393.009.4%4 703.009.8% +7.06%
Other521.001.1%247.000.5% -52.59%
Other Segment175.000.4%23.000% -86.86%
USD in Million
Sales per region
20192020Delta
United States20 325.0043.6%21 027.0043.8% +3.45%
Europe, Middle East and Africa12 707.0027.3%13 600.0028.3% +7.03%
China3 207.006.9%3 624.007.5% +13%
Japan3 583.007.7%3 376.007% -5.78%
Asia Pacific2 943.006.3%2 864.006% -2.68%
Latin America2 469.005.3%2 274.004.7% -7.9%
Other1 606.003.4%1 229.002.6% -23.47%
USD in Million
Managers
Name Title Age Since
Robert Davis President, Chief Executive Officer & Director 53 2021
Caroline Litchfield Chief Financial Officer & Executive Vice President - 2021
Sandy Tremps Vice President-R&D IT CIO - 2016
Dave Williams Chief Information & Digital Officer - -
Thomas Henry Glocer Independent Director 60 2007
Patricia Russo Independent Director 67 1995
Peter C. Wendell Independent Director 69 2003
Pamela J. Craig Independent Director 63 2015
Paul B. Rothman, Dr. Independent Director 62 2015
Inge Thulin Independent Director 66 2018
Members of the board
Name Title Age Since
Kenneth Frazier Executive Chairman 65 2021
Thomas Henry Glocer Independent Director 60 2007
Patricia Russo Independent Director 67 1995
Peter C. Wendell Independent Director 69 2003
Robert Davis President, Chief Executive Officer & Director 53 2021
Pamela J. Craig Independent Director 63 2015
Paul B. Rothman, Dr. Independent Director 62 2015
Inge Thulin Independent Director 66 2018
Mary Ellen Coe Independent Director 52 2019
Kathy Warden Independent Director 48 2020
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 3,575,725,843 2,529,536,185 70.7% 1,044,351,147 29.2% 70.7%
Shareholders
NameEquities%
The Vanguard Group, Inc. 214,913,278 8.49%
Capital Research & Management Co. 138,704,087 5.48%
SSgA Funds Management, Inc. 114,073,945 4.51%
BlackRock Fund Advisors 55,434,640 2.19%
Wellington Management Co. LLP 48,406,837 1.91%
Geode Capital Management LLC 44,209,748 1.75%
Northern Trust Investments, Inc.(Investment Management) 31,261,433 1.23%
Capital Research & Management Co. (International Investors) 28,915,476 1.14%
Norges Bank Investment Management 27,515,487 1.09%
Charles Schwab Investment Management, Inc. 26,293,818 1.04%
Holdings
NameEquities%Valuation
NGM BIOPHARMACEUTICALS, INC. (NGM) 12,955,016 16.8% 282,807,999 USD
SUTRO BIOPHARMA, INC. (STRO) 2,723,509 5.90% 59,154,615 USD
IMAGO BIOSCIENCES, INC. (IMGO) 1,193,046 3.57% 31,341,318 USD
4D PHARMA PLC (DDDD) 8,315,023 4.61% 10,093,191 USD
LAVA THERAPEUTICS B.V. (LVTX) 1,082,679 4.20% 7,091,547 USD
YUMANITY THERAPEUTICS, INC. (YMTX) 526,999 5.11% 5,691,589 USD
Markets and indexes
- International Market
- DJIA / S&P 100, S&P 500, Stoxx Americas 100, Stoxx Global 200, Stoxx NorthAmerica 50, Stoxx USA 50
Company contact information
Merck & Co., Inc.
2000 Road Galloping Hill
PO Box 100
NJ 07033 Kenilworth, New Jersey

Phone : +1 908 423 1000
Fax : +1 908 735 1253
web site : http://www.merck.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Merck & Co., Inc.
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
MERCK & CO., INC.-12.02%182 183
JOHNSON & JOHNSON4.54%433 122
ROCHE HOLDING AG9.82%321 584
PFIZER, INC.20.08%246 246
NOVO NORDISK A/S52.07%234 070
ELI LILLY AND COMPANY36.32%208 668
ABBVIE INC.0.00%189 353
NOVARTIS AG-7.87%186 591
ASTRAZENECA PLC18.92%184 103
BRISTOL-MYERS SQUIBB COMPANY-2.74%134 060
AMGEN INC.-6.33%122 293
SANOFI4.49%120 947
GLAXOSMITHKLINE PLC5.74%96 903
ALLERGAN PLC0.97%63 659
CHUGAI PHARMACEUTICAL CO., LTD.-24.97%62 138
TAKEDA PHARMACEUTICAL COMPANY LIMITED0.11%54 104
DAIICHI SANKYO COMPANY, LIMITED-14.57%52 973
BAYER AG-4.86%52 742
JIANGSU HENGRUI MEDICINE CO., LTD.-49.45%46 268
ASTELLAS PHARMA INC.17.69%31 819
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY50.05%24 794